review Open AccessTop 1% cited
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
BMC Cancer · 2010 · Vol. 10(1) · pp. 337–337
L. A. Smith✉(EES Research (United Kingdom))Victoria CorneliusChris Plummer(Freeman Hospital)Gill Levitt(Great Ormond Street Hospital)Mark Verrill(Newcastle upon Tyne Hospitals NHS Foundation Trust)Peter Canney(Gartnavel General Hospital)Alison Jones(University College Hospital)
Abstract
Evidence is not sufficiently robust to support clear evidence-based recommendations on different anthracycline treatment regimens, or for routine use of cardiac protective agents or liposomal formulations. There is a need to improve cardiac monitoring in oncology trials.
Chemotherapy-induced cardiotoxicity and mitigationCancer Treatment and PharmacologyCancer-related cognitive impairment studiesMedicineEpirubicinAnthracyclineCardiotoxicityInternal medicineConfidence intervalDoxorubicinBreast cancerOncologyRandomized controlled trial
MeSH terms
Antineoplastic AgentsFemaleHeart DiseasesHumansNeoplasmsMeta-Analysis as TopicRandomized Controlled Trials as TopicTreatment OutcomeAnthracyclines
Citations
742
FWCI
17.33
field-weighted impact
References
91
Percentile
99%
vs. same field & year
Citations per year
Cited by
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Annals of Oncology · 2020 · 963 citations
References
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
Annals of Internal Medicine · 1979 · 2,419 citations
Assessing the quality of controlled clinical trials
BMJ · 2001 · 3,343 citations
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Annals of Oncology · 2004 · 1,701 citations
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Annals of Oncology · 2003 · 1,013 citations
Measuring inconsistency in meta-analyses
BMJ · 2003 · 61,700 citations
Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events
Statistics in Medicine · 2006 · 935 citations
Pharmacological interventions for somatoform disorders in adults
Cochrane Database of Systematic Reviews · 2014 · 11,357 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.